Ticker >

Shree Ganesh BioTech share price

Shree Ganesh Bio-Tech (India) Ltd.

BSE: 539470 SECTOR: Agriculture  49k   110   14

1.21
0 0
BSE: 12 Apr 04:01 PM

Price Summary

Today's High

₹ 1.26

Today's Low

₹ 1.2

52 Week High

₹ 1.89

52 Week Low

₹ 0.7

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

48.23 Cr.

Enterprise Value

47.75 Cr.

No. of Shares

39.86 Cr.

P/E

118.63

P/B

0.77

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  1.57

CASH

0.48 Cr.

DEBT

0 Cr.

Promoter Holding

0 %

EPS (TTM)

₹  0.01

Sales Growth

-14.03%

ROE

3.32 %

ROCE

4.43%

Profit Growth

-19.29 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-14.03%
3 Year193.39%
5 Year51.38%

Profit Growth

1 Year-19.29%
3 Year105.23%
5 Year-10.25%

ROE%

1 Year3.32%
3 Year2.72%
5 Year2.75%

ROCE %

1 Year4.43%
3 Year3.69%
5 Year3.19%

Debt/Equity

0

Price to Cash Flow

4.58

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

2.16630162411649

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 0 0
Sep 2023 0 0
Jun 2023 0 0
Mar 2023 0 0
Dec 2022 0 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 193.387674902097% for the Past 3 years.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 35.380601864724 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.16630162411649.

 Limitations

  • Company has a poor ROE of 2.71685717855371% over the past 3 years.
  • Company has a poor ROCE of 3.69421596876759% over the past 3 years
  • Company has high debtor days of 184.734258540217.
  • The company is trading at a high EV/EBITDA of 118.0527.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 12.07 7.98 8.25 4.12 4.12
Total Expenditure 11.8 8.47 8.1 4.04 4.04
Operating Profit 0.27 -0.49 0.15 0.08 0.09
Other Income 0 0.58 0 0 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.27 0.1 0.15 0.08 0.09
Tax 0 0 0 0 0
Profit After Tax 0.27 0.1 0.15 0.08 0.09
Adjusted EPS (Rs) 0.01 0 0 0 0

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 5.87 2.47 17.21 72.64 62.45
Total Expenditure 4.08 2.24 16.51 69.19 60.3
Operating Profit 1.79 0.24 0.71 3.45 2.15
Other Income 0 0 0 0.05 0.56
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 -0.28 0 0
Profit Before Tax 1.79 0.24 0.43 3.5 2.71
Tax 0 0 0.11 0.97 0.68
Net Profit 1.79 0.24 0.32 2.53 2.04
Adjusted EPS (Rs.) 0.04 0.01 0.01 0.06 0.05

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 19.93 19.93 19.93 19.93 39.86
Total Reserves 37.31 37.54 37.86 40.39 22.49
Borrowings 0.19 0.19 0.19 0 0
Other N/C liabilities 0 0 0 0 0
Current liabilities 6.66 7.05 16.64 33.24 17.17
Total Liabilities 64.09 64.72 74.63 93.55 79.52
Assets
Net Block 0.01 0 0 0 0
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 3.06 3.22 0
Loans & Advances 44.85 43.86 43.16 46.36 59.68
Other N/C Assets 0 0 0 0 0
Current Assets 19.23 20.85 28.41 43.97 19.84
Total Assets 64.09 64.72 74.63 93.55 79.52
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 1.79 0.24 0.43 3.5 2.71
Adjustment 0 0 0 0 0
Changes in Assets & Liabilities -2.29 -1.25 2.05 1.04 8.5
Tax Paid 0 0 -0.11 -0.97 -0.68
Operating Cash Flow -0.5 -1.01 2.36 3.57 10.54
Investing Cash Flow -32.07 0.99 -2.36 -3.37 -10.09
Financing Cash Flow 32.58 0 0 -0.19 0
Net Cash Flow 0.01 -0.02 0.01 0.01 0.44

Corporate Actions

Investors Details

 No Promoters Data available for this company.
Report us
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 100.00 100.00 100.00 100.00 100.00
ashok kumar - - - - 1.26
new era fund limited 2.42 2.42 2.42 2.17 2.17
shiv corporation 13.10 13.10 13.10 3.66 -
shreeji capital partners - 6.55 6.55 4.04 -
krishna corporation 13.10 4.89 4.89 - -
llp - 1.12 - - -
nilmesh infrabuild llp - 1.12 - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Shree Ganesh BioTech - Quaterly Results13 Feb 2024, 4:49PM Shree Ganesh BioTech - Quaterly Results13 Feb 2024, 4:49PM Shree Ganesh Biotech (India) informs about revised disclosures19 Jan 2024, 1:09PM Shree Ganesh Biotech (India) informs about disclosure 19 Jan 2024, 1:03PM Shree Ganesh Biotech (India) submits certificate 22 Apr 2023, 3:57PM Shree Ganesh Biotech (India) informs about disclosure25 Feb 2023, 11:37AM Shree Ganesh Biotech (India) informs about outcome of board meeting15 Feb 2023, 2:37PM Shree Ganesh BioTech - Quaterly Results14 Feb 2023, 1:25PM Shree Ganesh Biotech (India) submits board meeting intimation 7 Feb 2023, 4:57PM Shree Ganesh BioTech - Quaterly Results9 Nov 2022, 3:57PM Shree Ganesh BioTech - Quaterly Results9 Nov 2022, 3:57PM Shree Ganesh BioTech - Quaterly Results9 Nov 2022, 3:57PM Shree Ganesh Biotech (India) informs about disclosures17 Sep 2022, 12:14PM Shree Ganesh Biotech (India) informs about outcome of board meeting 25 Jul 2022, 3:46PM Shree Ganesh BioTech - Quaterly Results25 Jul 2022, 12:11PM Shree Ganesh BioTech - Quaterly Results25 Jul 2022, 12:11PM Shree Ganesh BioTech - Quaterly Results25 Jul 2022, 12:11PM Shree Ganesh Bio-Tech (India) informs about board meeting7 Jul 2022, 9:48AM Shree Ganesh Bio-Tech (India) submits disclosure on related party transactions23 May 2022, 3:56PM Shree Ganesh Bio-Tech (India) informs about outcome of the board meeting23 May 2022, 3:53PM Shree Ganesh BioTech - Quaterly Results23 May 2022, 2:33PM Shree Ganesh BioTech - Quaterly Results23 May 2022, 2:33PM Shree Ganesh BioTech - Quaterly Results23 May 2022, 2:33PM Shree Ganesh Biotech (India) informs about disclosure27 Apr 2022, 5:09PM Shree Ganesh Biotech (India) informs about disclosure 27 Apr 2022, 10:00AM Shree Ganesh Bio-Tech (India) informs about outcome of board meeting7 Mar 2022, 4:50PM Shree Ganesh Bio-Tech (India) informs about board meeting3 Feb 2022, 10:44AM Shree Ganesh BioTech - Quaterly Results1 Feb 2022, 1:47PM Shree Ganesh BioTech - Quaterly Results1 Feb 2022, 1:47PM Shree Ganesh BioTech - Quaterly Results1 Feb 2022, 1:47PM Shree Ganesh Bio-Tech (India) informs about outcome of postal ballot notice22 Jan 2022, 3:04PM Shree Ganesh Bio-Tech (India) informs about record date29 Dec 2021, 10:07AM Shree Ganesh Biotech (India) informs about notice of postal ballot 21 Dec 2021, 4:25PM Shree Ganesh Bio-Tech informs about outcome of board meeting20 Dec 2021, 10:52AM Shree Ganesh Bio-Tech (India) informs about disclosure on related party transactions25 Jun 2021, 4:33PM Shree Ganesh Bio-Tech (India) informs about disclosure25 Jun 2021, 4:22PM Shree Ganesh Bio-Tech (India) informs about outcome of the board meeting25 Jun 2021, 4:15PM Shree Ganesh Biotech (India) informs about board meeting18 Jun 2021, 1:08PM Shree Ganesh BioTech (India) board to consider unaudited financial results 21 Oct 2020, 12:58PM Shree Ganesh BioTech India informs about updation of directors of company26 Aug 2020, 4:26PM Shree Ganesh Biotech India informs about compliance report24 Jul 2020, 3:45PM

Shree Ganesh BioTech Stock Price Analysis and Quick Research Report. Is Shree Ganesh BioTech an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Shree Ganesh BioTech has a PE ratio of 118.627450980392 which is high and comparatively overvalued .

  • Share Price: - The current share price of Shree Ganesh BioTech is Rs 1.21. One can use valuation calculators of ticker to know if Shree Ganesh BioTech share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Shree Ganesh BioTech has ROA of 2.35582870293066 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Shree Ganesh BioTech has a Current ratio of 1.15586042176395 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Shree Ganesh BioTech has a ROE of 3.32374972182528 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Shree Ganesh BioTech has a D/E ratio of 0 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Shree Ganesh BioTech has an Inventory turnover ratio of 0 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Shree Ganesh BioTech has reported revenue growth of -14.02685968047 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Shree Ganesh BioTech for the current financial year is 3.44234602790831 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Shree Ganesh BioTech is Rs 0 and the yield is 0 %.

Last Updated on:
Brief about Shree Ganesh BioTech
X